Manaris (2010) Corp./ US56176R1005 /
29/11/2023 18:31:52 | Var. - | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0000USD | - | 500 Fatturato: .0005 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0000 | 0.0000 |
GlobeNewswire
22:09
ROSEN, A LONGSTANDING LAW FIRM, Encourages UnitedHealth Group Inc. Investors to Secure Counsel Befor...
GlobeNewswire
22:05
The Simply Good Foods Company Completes Acquisition of Only What You Need (OWYN)
GlobeNewswire
22:05
iLearningEngines Partners with ULTS to Revolutionize Corporate Training with Learning Automation Pla...
GlobeNewswire
22:05
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
22:05
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire
22:05
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire
22:05
Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors
GlobeNewswire
22:03
Howard Hughes Holdings Inc. Closes on Refinancing of 9950 Woodloch Forest Drive in the Woodlands®
GlobeNewswire
22:01
WillScot Mobile Mini Holdings Announces Pricing of $500 Million Senior Secured Notes Offering
GlobeNewswire
22:01
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
22:01
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Director...
GlobeNewswire
22:01
IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable P...
GlobeNewswire
22:00
iCrowdNewswire ReleaseLive, Nominated Summer 2024 G2 Press Release Market Leader